VU-0152099

From WikiMD's WELLNESSPEDIA


Overview[edit]

VU-0152099 is a chemical compound that acts as a selective M1 receptor positive allosteric modulator. It is primarily used in scientific research to study the M1 muscarinic receptor and its role in cognitive function and neurological disorders.

Chemical Structure[edit]

Chemical structure of VU-0152099

VU-0152099 is characterized by its unique chemical structure, which allows it to selectively bind to the M1 muscarinic receptor. This selectivity is crucial for its role in modulating receptor activity without affecting other muscarinic receptors.

Mechanism of Action[edit]

VU-0152099 functions as a positive allosteric modulator of the M1 receptor. This means that it binds to a site on the receptor distinct from the orthosteric site where the endogenous ligand, acetylcholine, binds. By binding to this allosteric site, VU-0152099 enhances the receptor's response to acetylcholine, thereby potentiating its effects.

Research Applications[edit]

The compound is extensively used in preclinical studies to explore the therapeutic potential of M1 receptor modulation. It has been investigated for its effects on memory, learning, and synaptic plasticity. Researchers are particularly interested in its potential applications in treating Alzheimer's disease and other cognitive disorders.

Pharmacological Effects[edit]

Studies have shown that VU-0152099 can improve cognitive performance in animal models. It has been observed to enhance long-term potentiation (LTP) in the hippocampus, a brain region critical for memory formation. These effects are attributed to its ability to modulate M1 receptor activity.

Safety and Toxicology[edit]

As with many research chemicals, the safety profile of VU-0152099 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers must handle it with care, following appropriate safety protocols.

Future Directions[edit]

The ongoing research aims to better understand the role of M1 receptor modulation in cognitive processes and its potential therapeutic applications. VU-0152099 serves as a valuable tool in this research, helping to elucidate the complex mechanisms underlying neurotransmission and neurodegeneration.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=VU-0152099&oldid=6291277"